TenX Keane pays additional $268,645 to redeeming shareholders after redemption price miscalculation

CITIUS ONCOLOGY, INC.

Holders of 2,287,923 shares redeemed at $10.90/share on Jan 17, 2024, for ~$24.9M.
Correct redemption price should have been $11.02/share, based on Jan 12, 2024 calculation.
On May 31, 2024, company paid $268,645 aggregate top-up to cover the $0.12/share shortfall.
Total redemption amount adjusted to ~$25.2M using corrected price of $11.02 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.